CLUSTER filed Aug 5, 2026 at 17:15 ET
Two senior insiders at BeOne Medicines (CFO and SVP/General Counsel) sold a combined ~$700K in open-market sales within days of the company's strong Q2 earnings beat and raised guidance. While the dollar amount is trivial relative to the $35.9B market cap (0.002%), the timing, immediately after a bullish earnings report that sent the stock up, suggests routine post-earnings liquidity selling rather than bearish conviction. The cluster is not amplified by the proportionality threshold, and insider sales are weak predictors per academic literature, especially when clustered around common vesting/blackout windows.